Anti-apoptotic therapy for the treatment of retinal degeneration: basic science to clinical application

抗凋亡疗法治疗视网膜变性：基础科学到临床应用

• 批准号: 185647
• 负责人: Tsilfidis Catherine
• 金额: $ 0.27万
• 依托单位: Ottawa Hospital Research Institute
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2009
• 资助国家: 加拿大
• 起止时间: 2009-04-01 至 2010-04-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=185647&lang=en
• 关键词: Apoptosis; Gene Therapy; Nanoparticles; Retinal Degeneration

Cell death by apoptosis is the final common pathway for many forms of retinal disease, including glaucoma, retinitis pigmentosa, retinal ischemia, age-related macular degeneration and diabetic retinopathy. As such, any gene therapy strategy which targets

细胞凋亡导致的细胞死亡是多种视网膜疾病的最终共同途径，包括青光眼、视网膜色素变性、视网膜缺血、年龄相关性黄斑变性和糖尿病视网膜病变。因此，任何针对